publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. Highlights RNA-based agonists targeting RIG-I or MDA5 are at the center of an ongoing hunt for novel pan-antivirals, vaccine adjuvants, and antitumor strategies. 